Cell experiments show that many changes weakening a Zika protein’s interference with immunity also impair viral replication. A peer-reviewed study mapped the overlapping functions and identified combinations that reduced immune suppression while retaining replication. The resulting viruses were strongly weakened in mice carrying a human immune-signaling protein, providing preclinical evidence relevant to research on attenuated vaccine candidates.
Zika virus uses nonstructural protein five, known as NS5, both to copy its RNA and to interfere with antiviral immune signaling. A peer-reviewed experimental study in Nature Communications found substantial overlap between the protein regions supporting these jobs. Researchers compared changes in viral replication with changes in suppression of interferon, a signaling system that helps host cells respond to infection.[1]
Many individual amino-acid substitutions that weakened immune interference also damaged replication in cultured-cell tests. Mapping the two activities together revealed combinations of partially functional substitutions that retained replication while markedly reducing immune suppression. The researchers focused on interactions with STAT2, a host protein carrying interferon signals. The resulting pattern concerns a specific viral protein and host pathway rather than every mechanism used by Zika.[1]
Viruses carrying selected combinations of changes were strongly weakened in mice engineered to carry human STAT2. That host context matters because the Zika protein acts differently on human and ordinary mouse versions of the immune protein. The authors propose the functional separation as a route for research on attenuated vaccine candidates. The reported work remains preclinical, with human safety and protective immunity requiring further testing.[1]
